Abstract
A silicon-substituted hydroxyapatite has been prepared using tetraethylorthosilicate as a silicon source to obtain a biomaterial having an improved biocompatibility. From the XRD analysis, it was confirmed that the single-phase hydroxyapatite containing silicon has formed without revealing the presence of extra phases related to silicon oxide or other calcium phosphate species. Silicon content was up to 3.32% by weight. 29Si MAS NMR investigation elucidated the presence of tetrahedral silicate in the framework of hydroxyapatite structure. Substitution of silicon into the hydroxyapatite framework (Ca10(PO4)6-x(SiO4)x(OH) 2-x) reduced the amount of hydroxyl group to compensate for the extra negative charge of the silicate group, which is confirmed by FT-IR.
Original language | English |
---|---|
Pages (from-to) | 85-88 |
Number of pages | 4 |
Journal | Key Engineering Materials |
Volume | 218-220 |
State | Published - 2002 |
Event | 14th International Symposium on Ceramics in Medicine-Annual Meeting of the International Society for Ceramics in Medicine BIOCERAMICS'01 (ISCM) - Palm Springs, CA, United States Duration: 14 Nov 2001 → 17 Nov 2001 |